K
K

Dividends • Kiniksa Pharmaceuticals

KNSA

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
2/6/2024
2/21/2024
0,11
Quarterly
11/7/2023
11/22/2023
0,11
Quarterly
8/8/2023
8/23/2023
0,11
Quarterly
5/9/2023
5/24/2023
0,11
Quarterly
2/7/2023
2/22/2023
0,1
Quarterly